Research has shown that young people who face adversity such as traumatic or stressful events during brain development are 40% more likely to develop anxiety disorders by adulthood.
Genmab to buy ProfoundBio for $1.8 billion, the latest deal focused on targeted chemotherapies
LONDON — The Danish firm Genmab said Wednesday it would acquire ProfoundBio for $1.8 billion in cash, the latest in a string of 10-figure deals